MRI-Guided Cryoablation of In-Transit Metastases from Cutaneous Melanoma: A Brief Report on a Preliminary Experience.

2.50
Hdl Handle:
http://hdl.handle.net/11287/620334
Title:
MRI-Guided Cryoablation of In-Transit Metastases from Cutaneous Melanoma: A Brief Report on a Preliminary Experience.
Authors:
Rauch, A.; Cazzato, R. L.; Garnon, J.; Shaygi, Behnam; Tsoumakidou, G.; Caudrelier, J.; Bauones, S.; Koch, G.; Lipsker, D.; Gangi, A.
Abstract:
This study aims to discuss MRI-guided cryoablation (CA) of in-transit (IT) metastases from melanoma and to retrospectively present our preliminary experience in such a specific field. Three female patients (mean age 55.6 years; range 39-64) were included, and eight IT metastases (mean size 12.4 ± 6.5 mm, range: 5-25) were treated in three different sessions. Technical success was 100%; and mean procedural time 129.3 ± 103 min. (range 42-243). Primary local tumour control was 100% at 1-, 6- and 12-month follow-up; and 87.5% at 18-month follow-up. Two complications were recorded (one minor and one major). MRI-guided CA is a novel therapy, which may be included in the armamentarium of local therapies of IT metastases.
Citation:
MRI-Guided Cryoablation of In-Transit Metastases from Cutaneous Melanoma: A Brief Report on a Preliminary Experience. 2017 Cardiovasc Intervent Radiol
Publisher:
Springer
Journal:
Cardiovascular and interventional radiology
Issue Date:
4-Apr-2017
URI:
http://hdl.handle.net/11287/620334
DOI:
10.1007/s00270-017-1645-x
PubMed ID:
28378049
Additional Links:
https://dx.doi.org/10.1007/s00270-017-1645-x
Type:
Journal Article
Language:
en
ISSN:
1432-086X
Appears in Collections:
Radiology Department; 2017 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorRauch, A.en
dc.contributor.authorCazzato, R. L.en
dc.contributor.authorGarnon, J.en
dc.contributor.authorShaygi, Behnamen
dc.contributor.authorTsoumakidou, G.en
dc.contributor.authorCaudrelier, J.en
dc.contributor.authorBauones, S.en
dc.contributor.authorKoch, G.en
dc.contributor.authorLipsker, D.en
dc.contributor.authorGangi, A.en
dc.date.accessioned2017-05-17T15:51:14Z-
dc.date.available2017-05-17T15:51:14Z-
dc.date.issued2017-04-04-
dc.identifier.citationMRI-Guided Cryoablation of In-Transit Metastases from Cutaneous Melanoma: A Brief Report on a Preliminary Experience. 2017 Cardiovasc Intervent Radiolen
dc.identifier.issn1432-086X-
dc.identifier.pmid28378049-
dc.identifier.doi10.1007/s00270-017-1645-x-
dc.identifier.urihttp://hdl.handle.net/11287/620334-
dc.description.abstractThis study aims to discuss MRI-guided cryoablation (CA) of in-transit (IT) metastases from melanoma and to retrospectively present our preliminary experience in such a specific field. Three female patients (mean age 55.6 years; range 39-64) were included, and eight IT metastases (mean size 12.4 ± 6.5 mm, range: 5-25) were treated in three different sessions. Technical success was 100%; and mean procedural time 129.3 ± 103 min. (range 42-243). Primary local tumour control was 100% at 1-, 6- and 12-month follow-up; and 87.5% at 18-month follow-up. Two complications were recorded (one minor and one major). MRI-guided CA is a novel therapy, which may be included in the armamentarium of local therapies of IT metastases.en
dc.language.isoenen
dc.publisherSpringeren
dc.relation.urlhttps://dx.doi.org/10.1007/s00270-017-1645-xen
dc.rightsArchived with thanks to Cardiovascular and interventional radiologyen
dc.subjectWessex Classification Subject Headings::Radiologyen
dc.titleMRI-Guided Cryoablation of In-Transit Metastases from Cutaneous Melanoma: A Brief Report on a Preliminary Experience.en
dc.typeJournal Articleen
dc.identifier.journalCardiovascular and interventional radiologyen
dc.type.versionIn press (epub ahead of print)en

Related articles on PubMed

All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.